Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma.

D C Case(Maine Medical Center), Brian M. Dorsk, M C Gerber, Richard A. Gams(Breast Center), Thomas J. Ervin(Bayfront Medical Center), Daniel M. Hayes

PubMed

November 1, 1990

Cited by 33

Related Papers

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

|New England Journal of Medicine|2013|6.6k

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

|New England Journal of Medicine|2007|1.7k

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2014|1.7k

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

|Journal of Clinical Oncology|1997|652

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

|International Journal of Radiation Oncology*Biology*Physics|1992|413